Regulating renal drug elimination?

Journal of the American Society of Nephrology

Volumn 16, Issue 6, 2005, Pages 1535-1536

  Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CATION TRANSPORT PROTEIN; PROTEIN KINASE C; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; XENOBIOTIC AGENT; ORGANIC CATION TRANSPORTER;

CATION TRANSPORT; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG SENSITIVITY; EDITORIAL; ENZYME ACTIVATION; KIDNEY TUBULE ABSORPTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; URINARY EXCRETION; HUMAN; KIDNEY; METABOLIC CLEARANCE RATE; NOTE; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; HUMANS; KIDNEY; METABOLIC CLEARANCE RATE; ORGANIC CATION TRANSPORT PROTEINS; PROTEIN KINASE C; XENOBIOTICS;

EID: 26944486690     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005030311     Document Type: Editorial

References (24)

1. Koepsell H, Schmitt BM, Gorboulev V: Organic cation transporters. Rev Physiol Biochem Pharmacol 150: 36-90, 2003
2. Lee W, Kim RB: Transporters and renal drug elimination. Annu Rev Pharmacol Toxicol 44: 137-166, 2004
3. Marzolini C, Tirona RG, Kim RB: Pharmacogenomics of the OATP and OAT families. Pharmacogenomics 5: 273-282, 2004
4. Schwab M, Eichelbaum M, Fromm MF: Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev Pharmacol Toxicol 43: 285-307, 2003
5. Cutler RE, Forland SC: Pharmacokinetics of drugs and the effects of renal failure. In: Textbook of Nephrology, edited by Massry SG, Glassock RJ, Philadelphia, Lippincott Williams & Wilkins, 2001
6. Ciarimboli G, Koepsell H, Iordanova M, Gorboulev V, Durner B, Lang D, Edemir B, Schröter R, Van Le T, Schlatter E: Individual PKC-phosphorylation sites in organic cation transposter 1 determine substrate selectivity and transport regulation. J Am Soc Nephrol 16: 1562-1570, 2005
7. Ciarimboli G, Schlatter E: Regulation of organic cation transport. Pflugers Arch 449: 423-441, 2005
8. Pietig G, Mehrens T, Hirsch JR, Cetinkaya I, Piechota H, Schlatter E: Properties and regulation of organic cation transport in freshly isolated human proximal tubules. J Biol Chem 276: 33741-33746, 2001
9. Awazu M, Ishikura K, Hida M, Hoshiya M: Mechanisms of mitogen-activated protein kinase activation in experimental diabetes. J Am Soc Nephrol 10: 738-745, 1999
10. Ceol M, Gambaro G, Sauer U, Baggio B, Anglani F, Forino M, Facchin S, Bordin L, Weigert C, Nerlich A, Schleicher ED: Glycosaminoglycan therapy prevents TGF-betal overexpression and pathologic changes in renal tissue of long-term diabetic rats. J Am Soc Nephrol 11: 2324-2336, 2000
11. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB: Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002
12. Hayashida T, Schnaper HW: High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal-regulated kinase and protein kinase Cdelta activities in human mesangial cells. J Am Soc Nephrol 15: 2032-2041, 2004
13. Lee GT, Ha H, Jung M, Li H, Hong SW, Cha BS, Lee HC, Cho YD: Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J Am Soc Nephrol 14: 709-720, 2003
14. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H: Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14: S241-S245, 2003
15. Menne J, Park JK, Boehne M, Elger M, Lindschau C, Kirsch T, Meier M, Gueler F, Fiebeler A, Bahlmann FH, Leitges M, Haller H: Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes 53: 2101-2109, 2004
16. Yoo CW, Song CY, Kim BC, Hong HK, Lee HS: Glycated albumin induces superoxide generation in mesangial cells. Cell Physiol Biochem 14: 361-368, 2004
17. Chen DH, Brkanac Z, Verlinde CL, Tan XJ, Bylenok L, Nochlin D, Matsushita M, Lipe H, Wolff J, Fernandez M, Cimino PJ, Bird TD, Raskind WH: Missense mutations in the regulatory domain of PKC gamma: A new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet 72: 839-849, 2003
18. Ikeda Y, Suehiro T, Osaki F, Tsuzura S, Kumon Y, Hashimoto K: Polymorphisms in the 5′-upstream region of the PKCbeta gene in Japanese patients with type 2 diabetes. Diabet Med 21: 1113-1120, 2004
19. Knauf JA, Ward LS, Nikiforov YE, Nikiforova M, Puxeddu E, Medvedovic M, Liron T, Mochly-Rosen D, Fagin JA: Isozyme-specific abnormalities of PKC in thyroid cancer: Evidence for post-transcriptional changes in PKC epsilon. J Clin Endocrinol Metab 87: 2150-2159, 2002
20. Kofler K, Erdel M, Utermann G, Baier G: Molecular genetics and structural genomics of the human protein kinase C gene module. Genome Biol 3: RESEARCH0014, 2002
21. Busjahn A, Aydin A, Uhlmann R, Krasko C, Bahring S, Szelestei T, Feng Y, Dahm S, Sharma AM, Luft FC, Lang F: Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure. Hypertension 40: 256-260, 2002
22. Lang F, Klingel K, Wagner CA, Stegen C, Warntges S, Friedrich B, Lanzendorfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, Broer S: Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A 97: 8157-8162, 2000
23. Lang F, Henke G, Embark HM, Waldegger S, Palmada M, Bohmer C, Vallon V: Regulation of channels by the serum and glucocorticoid-inducible kinase-Implications for transport, excitability and cell proliferation. Cell Physiol Biochem 13: 41-50, 2003
24. Pearce D: SGK1 regulation of epithelial sodium transport. Cell Physiol Biochem 13: 13-20, 2003